NYSEMKT: KAPA
Kairos Pharma Ltd Stock Forecast, Predictions & Price Target

Analyst price target for KAPA

Based on 3 analysts offering 12 month price targets for Kairos Pharma Ltd

Min Forecast
$4.00+545.16%
Avg Forecast
$8.33+1,244.03%
Max Forecast
$12.00+1,835.48%

Should I buy or sell KAPA stock?

Based on 3 analysts offering ratings for Kairos Pharma Ltd.

Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their KAPA stock forecasts and price targets.

KAPA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-04-17
lockedlocked$00.00+00.00%2025-04-03
lockedlocked$00.00+00.00%2025-03-27

1 of 1

KAPA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
KAPA$0.62$8.33+1,244.03%Strong Buy
CYCN$3.12N/AN/A
ABP$0.21$4.00+1,851.22%Strong Buy
CAPS$1.92N/AN/A
IMRN$1.91N/AN/A

Kairos Pharma Stock Forecast FAQ

Is Kairos Pharma Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NYSEMKT: KAPA) stock is to Strong Buy KAPA stock.

Out of 3 analysts, 2 (66.67%) are recommending KAPA as a Strong Buy, 1 (33.33%) are recommending KAPA as a Buy, 0 (0%) are recommending KAPA as a Hold, 0 (0%) are recommending KAPA as a Sell, and 0 (0%) are recommending KAPA as a Strong Sell.

If you're new to stock investing, here's how to buy Kairos Pharma stock.

What is KAPA's Price Target?

According to 3 Wall Street analysts that have issued a 1 year KAPA price target, the average KAPA price target is $8.33, with the highest KAPA stock price forecast at $12.00 and the lowest KAPA stock price forecast at $4.00.

On average, Wall Street analysts predict that Kairos Pharma's share price could reach $8.33 by Apr 17, 2026. The average Kairos Pharma stock price prediction forecasts a potential upside of 1,244.03% from the current KAPA share price of $0.62.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.